AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CQS New City High Yield Fund Ltd

Pre-Annual General Meeting Information Oct 21, 2025

10464_agm-r_2025-10-21_48153ffe-6881-4607-ab1d-49a69242851b.pdf

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

Notice of Annual General Meeting

NOTICE is hereby given that the nineteenth Annual General Meeting of CQS New City High Yield Fund Limited (the Company) will be held at the Company's registered office of IFC1, The Esplanade, St. Helier, Jersey, JE1 4BP on 4 December 2025 at 11:00 a.m. GMT for the following purpose:

To consider and, if thought fit, pass resolutions 1 to 10 as ordinary resolutions and resolutions 11 to 13 as special resolutions:

Ordinary Business

    1. To receive the directors' report and audited financial statements of the Company for the year ended 30 June 2025, together with the auditors' report thereon.
    1. To approve the directors' remuneration report in the form set out in the Company's annual financial report for 2025.
    1. To approve the Company's Dividend Policy.
    1. To re-elect Ms Caroline Hitch as a director of the Company.
    1. To elect Mr Andrew Dann as a director of the Company.
    1. To re-elect Mr John Newlands as a director of the Company.
    1. To re-elect Mr Ian Cadby as a director of the Company.
    1. To re-appoint PricewaterhouseCoopers LLP as the Company's independent auditors.
    1. To authorise the directors to agree the remuneration of the Company's independent auditors.
    1. That, pursuant to Article 172 of the Company's Articles of Association, the Company shall continue as an investment fund until the conclusion of the next Annual General Meeting of the Company.

Special Business

    1. That, the Company be authorised to issue equity securities (as defined in Article 16.2 of the Company's Articles of Association) for cash, as if the provisions of Article 16.2 did not apply to any such issue, including by way of a sale of ordinary shares held by the Company as treasury shares, in such amount as represents up to 10% of the Company's issued share capital as at the date of the passing of this resolution, provided that such authorisation shall expire (unless and to the extent previously revoked, varied or renewed by the Company in general meeting by Special Resolution) at the earlier of the conclusion of the next annual general meeting of the Company or eighteen months from the date of this resolution but so that this power shall enable the Company to make offers or agreements before such expiry which would or might require equity securities to be issued after such expiry and the directors of the Company may issue equity securities in pursuance of any such offer or agreement as if such expiry had not occurred.
    1. That, the Company be authorised to issue equity securities (as defined in Article 16.2 of the Company's Articles of Association) for cash, as if the provisions of Article 16.2 did not apply to any such issue, including by way of a sale of ordinary shares held by the Company as treasury shares, in such amount as represents up to 10% of the Company's issued share capital as at the date of the passing of this resolution, provided that such authorisation shall expire (unless and to the extent previously revoked, varied or renewed by the Company in general meeting by Special Resolution) at the earlier of the conclusion of the next annual general meeting of the Company or eighteen months from the date of this resolution but so that this power shall enable the Company to make offers or agreements before such expiry

which would or might require equity securities to be issued after such expiry and the directors of the Company may issue equity securities in pursuance of any such offer or agreement as if such expiry had not occurred.

The authority granted by this Resolution 12 shall be in addition to, and not in place of, the authority set out in Resolution 11 and any subsequent renewal thereof.

    1. That, pursuant to Article 57 of the Companies (Jersey) Law 1991, the Company be generally and unconditionally authorised to make one or more market purchases of ordinary shares of no par value in the capital of the Company (ordinary shares) provided that:
  • (i) the maximum aggregate number of ordinary shares authorised to be purchased shall be equal to 14.99% of the total issued share capital of the Company on the date at which the resolution is passed;
  • (ii) the minimum price which may be paid by the Company for an ordinary share is 1p;
  • (iii) the maximum price, exclusive of expenses, which may be paid for an ordinary share is an amount equal to the higher of:
    • (a) 105% of the average of the middle market quotations for an ordinary share as derived from the Daily Official List of the LSE for the five business days immediately preceding the day on which the ordinary share is purchased; and
    • (b) the higher of (1) the price of the last independent trade in ordinary shares and (2) the highest current independent bid for ordinary shares on the LSE's Main Market;
  • (iv) any ordinary shares to be purchased may be cancelled or held as treasury shares in accordance with the Companies (Jersey) Law, 1991, provided that the Company shall not hold as treasury shares more than 10% of the aggregate number of ordinary shares in issue at any one time;
  • (v) this authority expires at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or fifteen months from the date of the passing of this resolution, whichever is earlier;
  • (vi) the Company may make a contract to purchase ordinary shares under this authority before the expiry of the authority which will or may be executed wholly or partly after the expiry of the authority and may make a purchase of ordinary shares in pursuance of any such contract; and
  • (vii) the Directors provide a statement of solvency in accordance with Articles 55 and 57 of the Companies (Jersey) Law, 1991.

The Company requests that any Shareholders wishing to attend the Annual General Meeting to advise the Company Secretary by email or in writing as detailed in note 3 below.

By Order of the Board

BNP Paribas S.A., Jersey Branch Company Secretary 8 October 2025

Notes:

    1. Information about this meeting is available from the Company's website; www.ncim.co.uk
    1. As a member who is entitled to attend and vote at this meeting you are entitled to appoint one or more proxies to exercise all or any of your rights to attend, speak and vote on your behalf. Such a proxy need not also be a member of the Company. You may appoint more than one proxy provided each proxy is appointed to exercise rights attached to different shares. You may not appoint more than one proxy to exercise the rights attached to any one share.
    1. Any Shareholder wishing to attend the Annual General Meeting can advise the Company of their intention to do so by writing to the Company Secretary at BNP Paribas S.A., Jersey Branch, IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP or by email at [email protected].
    1. A form of proxy is enclosed for use at the meeting. To be valid, the proxy card and any power of attorney or other authority, if any, under which it is signed, or a certified copy thereof must be lodged with the Company's registrar, Computershare Investor Services (Jersey) Limited, c/o The Pavilions, Bridgwater Road, Bristol BS99 6ZZ at least 48 hours before the meeting.
    1. Completion of the proxy card will not prevent a Shareholder from attending the meeting and voting in person.
  • Pursuant to Article 40 of the Companies (Uncertificated Securities) (Jersey) Order 1999, the Company has specified that only those Shareholders registered on the register of members of the Company as at 6.00 pm on 02 December 2025, or in the event that the meeting is adjourned, on the register of members 48 hours before the time of the meeting, shall be entitled to attend and vote at the meeting in respect of the number of shares registered in their name at that relevant time. Changes to entries on the register of members after 6.00 pm on 25 November 2025, or in the event that the meeting is adjourned to a later time, on the register of members 48 hours before the time of any adjourned meeting, shall be disregarded in determining the rights of any person to attend and vote at the meeting.

Electronic receipt of proxies

  1. To appoint one or more proxies or give an instruction to a proxy (whether previously appointed or otherwise) via the CREST system, CREST messages must be received by the Company's agent (ID number 3RA50) no later than the 02 December 2025 at 11am. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp generated by the CREST system) from which the issuer's agent is able to retrieve the message. The Company may treat as invalid a proxy appointment sent by CREST in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001 or Article 34 of the Companies (Uncertificated Securities) (Jersey) Order 1999. Instructions on how to vote through CREST can be found on the website www.euroclear.com

Explanation of AGM resolutions

Resolution 1: Annual Financial Statements and Directors' and Auditor's Reports

The Directors are required to lay before the AGM copies of the directors' report and audited financial statements of the Company for the year ended 30 June 2025, together with the auditors' report thereon (2025 Annual Report). Shareholders will be given an opportunity at the meeting to ask questions on these items before being invited to receive them.

Resolution 2: Remuneration Report

As a Jersey domiciled Company, the Directors are not required to present its remuneration policy to Shareholders at the AGM. In line with best practice, however, the Directors present the remuneration report in the form set out in the Company's 2025 Annual Report to Shareholders for approval.

Resolution 3: Dividend Policy

To approve the Company's dividend policy as detailed on page 43 of its 2025 Annual Report.

Resolutions 4 to 7: Re-election and appointment of Directors

In accordance with the recommendations of the AIC Code of Corporate Governance, all Directors apart from Ms Wendy Dorman, who is due to retire at the AGM, and Mr Dann who stands for election, put themselves forward for re-election.

Resolutions 8 and 9: Re-appointment and Remuneration of the Auditor

Shareholders are requested to approve the reappointment of the Company's Auditor, PricewaterhouseCoopers CI LLP, and are also asked to give Directors the authority to determine the Auditor's remuneration. PricewaterhouseCoopers CI LLP has expressed its willingness to continue as Auditor of the Company.

Resolution 10: Continuation Vote

In accordance with the Company's Articles of Association (the Articles), this resolution proposes to continue the Company as an investment company. In the event that the resolution is not passed, the Board would put forward further proposals at an extraordinary general meeting to liquidate or reconstruct the Company.

Resolution 11 and 12: Directors' Authority to Allot Shares

Pursuant to the Company's Articles, the Directors are required to seek a disapplication of preemption rights from Shareholders before issuing new shares on a non-pre-emptive basis. In order to continue with its programme of new share issues, the Board is therefore proposing that the annual disapplication of pre-emption rights authority is given to the Directors so that they may continue to issue shares as and when appropriate.

Accordingly, Resolutions 11 and 12 authorise the Board to allot on a non-pre-emptive basis:

  • (a) (pursuant to Resolution 11) up to 10% of the issued ordinary share capital of the Company; and
  • (b) (pursuant to Resolution 12) up to a further 10% of the issued ordinary share capital of the Company.

If both Resolution 11 and Resolution 12 are passed, Shareholders will be granting the Directors the authority to allot a total of up to 20% of the existing issued ordinary share capital of the Company in aggregate on a non-pre-emptive basis. If Resolution 11 is passed but Resolution 12 is not passed, Shareholders will only be granting Directors the authority to allot up to 10% of the existing issued ordinary share capital of the Company on a non-pre-emptive basis.

New ordinary shares will not be issued at a price less than the prevailing NAV per ordinary share, after taking into account any costs incurred by the Company in connection with such issue. Any issues of new ordinary shares will be carried out in accordance with the UK Listing Rules.

Each of the authorities granted pursuant to Resolution 11 and Resolution 12 shall expire on the earlier of eighteen months from the date of the resolution or at the conclusion of the next Annual General Meeting.

The authority granted by Resolution 12 shall be in addition to, and not in place of, the authority set out in Resolution 11 and any subsequent renewal thereof.

Resolution 13: Directors' Authority to Buy Back Shares

The current authority of the Company to make purchases of up to approximately 14.99% of its issued capital expires at the end of the Annual General Meeting and Resolution 13 seeks renewal of such authority until the next Annual General Meeting (or the expiry of fifteen months from the date of the passing of the resolution, if earlier). The maximum and minimum prices to be paid for shares are set out in Resolution 13. This power will be exercised only if, in the opinion of the Directors, a repurchase would result in an increase in NAV per ordinary share and would be in the best interests of Shareholders as a whole. Any shares purchased under this authority will either be held in treasury or cancelled.

CQS NEW CITY HIGH YIELD FUND LIMITED

All Correspondence to:

Computershare Investor Services (Jersey) Limited c/o The Pavilions, Bridgwater Road, Bristol, BS99 6ZY

Form of Proxy - Annual General Meeting to be held on 4 December 2025

Cast your Proxy online...It's fast, easy and secure! www.investorcentre.co.uk/eproxy

You will be asked to enter the Control Number, Shareholder Reference Number (SRN) and PIN shown opposite and agree to certain terms and conditions.

PIN: SRN:

Control Number: 921058

View the Notice of Meeting online: https://ncim.co.uk/cqs-new-city-high-yield-fund-ltd/

Register at www.investorcentre.co.uk - elect for electronic communications & manage your shareholding online!

To be effective, all proxy appointments including this Form and the power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power of attorney must be lodged with the Company's Registrars at: c/o The Pavilions, Bridgwater Road, Bristol BS99 6ZY by 2 December 2025 at 11.00 am.

Explanatory Notes:

    1. Every holder has the right to appoint some other person(s) of their choice, who need not be a shareholder, as their proxy to exercise all or any of their rights, to attend, speak and vote on their behalf at the meeting. If you wish to appoint a person other than the Chairman, please insert the name of your chosen proxy holder in the space provided (see reverse). If the proxy is being appointed in relation to less than your full voting entitlement, please enter in the box next to the proxy holder's name (see reverse) the number of shares in relation to which they are authorised to act as your proxy. If returned without an indication as to how the proxy shall vote on any particular matter, the proxy will exercise their discretion as to whether, and if so how, they vote (or if this proxy form has been issued in respect of a designated account for a shareholder, the proxy will exercise their discretion as to whether, and if so how, they vote).
    1. To appoint more than one proxy, an additional proxy form(s) may be obtained by contacting the Registrar's helpline on 0370 707 4040 or you may photocopy this form. Please indicate in the box next to the proxy holder's name (see reverse) the number of shares in relation to which they are authorised to act as your proxy. Please also indicate by marking the box provided if the proxy instruction is one of multiple instructions being given. All forms must be signed and should be returned together in the same envelope.
    1. The 'Vote Withheld' option overleaf is provided to enable you to abstain on any particular resolution. However, it should be noted that a 'Vote Withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.
    1. Pursuant to Article 40 of the Companies (Uncertificated Securities) (Jersey) Order 1999, entitlement to attend and vote at the meeting and the number of votes which may be cast thereat will be determined by reference to the Register of Members of the Company at close of business on the day which is two days (excluding non-working days) before the day of the meeting. Changes to entries on the Register of Members after that time shall be disregarded in determining the rights of any person to attend and vote at the meeting.
    1. To appoint one or more proxies or to give an instruction to a proxy (whether previously appointed or otherwise) via the CREST system, CREST messages must be received by the issuer's agent (ID number 3RA50) not later than 48 hours before the time appointed for holding the meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp generated by the CREST system) from which the issuer's agent is able to retrieve the message. The Company may treat as invalid a proxy appointment sent by CREST in the circumstances set out in Article 34 of the Companies (Uncertificated Securities) (Jersey) Order 1999.
    1. The above is how your address appears on the Register of Members. If this information is incorrect please ring the Registrar's helpline on 0370 707 4040 to request a change of address form or go to www.investorcentre.co.uk/je to use the online Investor Centre service.
    1. Any alterations made to this form should be initialled.
    1. The completion and return of this form will not preclude a member from attending the meeting and voting in person.
    1. If you do not follow these instructions, any instrument you make appointing a proxy may be invalid.
    1. In the case of jointly held shares, if more than one joint holder purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. For this purpose, seniority will be determined by the order in which the names of the joint holders appear in the register of members (the first-named being the most senior.

Kindly Note: This form is issued only to the addressee(s) and is specific to the unique designated account printed hereon. This personalised form is not transferable between different: (i) account holders; or (ii) uniquely designated accounts. The Company and Computershare Investor Services (Jersey) Limited accept no liability for any instruction that does not comply with these conditions.

All Named Holders
Form of Proxy
Please complete this box only if you wish to appoint a third party proxy other than the Chair.
Please leave this box blank if you want to select the Chair. Do not insert your own name(s).
*
I/We hereby appoint the Chair of the Meeting OR the person indicated in the box above as my/our proxy to attend, speak and vote in respect of my/our full voting entitlement*
on my/our behalf at the Annual General Meeting of CQS New City High Yield Fund Limited to be held at IFC1, The Esplanade, St. Helier, Jersey, JE1 4BP
on 4 December 2025 at 11.00 am, and at any adjourned meeting.
* For the appointment of more than one proxy, please refer to Explanatory Note 2 (see front).
Please use a black pen. Mark with an X
Please mark here to indicate that this proxy appointment is one of multiple appointments being made.
inside the box as shown in this example.
1. Ordinary Business
To receive the directors' report and audited financial statements of the Company for the year ended 30 June 2025, together with the auditors' report
thereon.
For Against Vote
Withheld
2. To approve the directors' remuneration report in the form set out in the Company's annual financial report for 2025.
3. To approve the Company's Dividend Policy.
4. To re-elect Ms Caroline Hitch as a director of the Company.
5. To elect Mr Andrew Dann as a director of the Company.
6. To re-elect Mr John Newlands as a director of the Company.
7. To re-elect Mr Ian Cadby as a director of the Company.
8. To re-appoint PricewaterhouseCoopers LLP as the Company's independent auditors.
9. To authorise the directors to agree the remuneration of the Company's independent auditors.
10. That, pursuant to Article 172 of the Company's Articles of Association, the Company shall continue as an investment fund until the conclusion of the next
Annual General Meeting of the Company.
Special Business
11. That, the Company be authorised to issue equity securities for cash, including by way of a sale of ordinary shares held by the Company as treasury
shares, in such amount as represents up to 10% of the Company's issued share capital as per the terms set out in the notice of meeting.
12. That, in addition to any authority granted under Resolution 11 above, the Company be authorised to issue equity securities for cash, including by way of a
sale of ordinary shares held by the Company as treasury shares, in such amount as represents up to 10% of the Company's issued share capital as at
the date of the passing of this resolution as per the terms set out in the notice of meeting.
13. That, pursuant to Article 57 of the Companies (Jersey) Law 1991, the Company be generally and unconditionally authorised to make one or more market
purchases of ordinary shares of no par value in the capital of the Company as per the terms set out in the notice of meeting.
I/We instruct my/our proxy as indicated on this form. Unless otherwise instructed the proxy may vote as they see fit or abstain in relation to any business of the meeting.
Signature
Date
In the case of a corporation, this proxy must be given under its
common seal or be signed on its behalf by an attorney or officer duly
authorised, stating their capacity (e.g. director, secretary).

H 7 5 3 2 1 N EW J

Talk to a Data Expert

Have a question? We'll get back to you promptly.